InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+50.8%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Sherman Jeffrey Scott, 首席财务官. Director active across 2 companies, notably Privia Health Group, Inc.. Aggregated, 12 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €229k. History available since 5 January 2022. The latest transaction was filed on 21 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sherman Jeffrey Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
42,158 股0Common StockSEC:0001628280-26-011099:0
11,938 股0Common StockSEC:0001628280-25-056080:0
20,000 股@ US$5.616142.0% 占其流量Common StockSEC:0001628280-25-038324:0
标准退出：2025年11月4日 (T+90)
13,005 股0Common StockSEC:0001077183-25-000105:0
20,000 股@ US$7.5052100.0% 占其流量Common StockSEC:0001077183-25-000090:0
标准退出：2025年7月31日 (T+90)
15,535 股0Common StockSEC:0001077183-25-000040:0
11,746 股0Common StockSEC:0001077183-24-000172:0
13,005 股0Common StockSEC:0001077183-24-000169:0
13,005 股0Common StockSEC:0001077183-24-000072:0
8,147 股0Common StockSEC:0001077183-23-000144:0
44,603 股0Common StockSEC:0001077183-22-000202:0
61,307 股0Common Stock, $0.01 par value per shareSEC:0001759655-22-000009:0
12 条申报中的 12 条
About Sherman Jeffrey Scott
Sherman Jeffrey Scott is Chief Financial Officer. He has 12 filings in total. Across the 12 sampled filings, the transactions are buys tied to option exercise, for a total amount of EUR 229181, with recent filings dated from 2022-01-07 to 2026-02-24. The companies mentioned in his filings are Neogenomics INC and Privia Health Group, Inc.
